Based on Li Jie (李杰), Compound Interest Believer (复利信徒) (2020)
Li Jie's central conviction is that compounding — the exponential growth of capital over time — is the single most powerful force in investing, yet the one least respected by most market participants. The book is not about finding the next ten-bagger in a year. It is about constructing a process that generates 15-25% annualized returns over 10-20 years, allowing compound interest to do the heavy lifting of wealth creation.
The core argument rests on three pillars:
Compounding requires time. A 20% annualized return held for 20 years turns 1 into 38.3. The same return held for 5 years only turns 1 into 2.5. Most investors destroy their compounding trajectory by trading too frequently, cutting winners short, and resetting the compounding clock.
Compounding requires quality. Only businesses with durable competitive advantages can sustain high returns on capital long enough for compounding to work. A mediocre business that earns 8% ROE does not compound meaningfully even over decades. The engine of compounding is the underlying business, not the stock price.
Compounding requires discipline. The investor must resist the behavioral traps that interrupt compounding: panic selling in bear markets, chasing momentum in bull markets, over-diversifying out of fear, and confusing activity with progress.
Li Jie writes from the perspective of a Chinese A-share investor who has studied Buffett, Munger, and the Western value investing canon, then adapted those principles to the specific realities of China's capital markets — higher volatility, retail-dominated trading, periodic regulatory shocks, and a rapidly evolving economic landscape. The book bridges Graham-Dodd fundamentalism with the practical challenges of investing in Chinese equities.
The operational goal: identify 8-15 exceptional businesses, buy them at or below fair value, hold them for 3-10 years, and let the underlying ROE compound shareholder value. Sell only when the business deteriorates, valuation reaches extreme overvaluation, or a clearly superior opportunity appears.
Li Jie insists investors internalize the raw math before making any investment decision:
| Annualized Return | 5 Years | 10 Years | 15 Years | 20 Years | 30 Years |
|---|---|---|---|---|---|
| 10% | 1.61x | 2.59x | 4.18x | 6.73x | 17.4x |
| 15% | 2.01x | 4.05x | 8.14x | 16.4x | 66.2x |
| 20% | 2.49x | 6.19x | 15.4x | 38.3x | 237x |
| 25% | 3.05x | 9.31x | 28.4x | 86.7x | 808x |
Key insight: the difference between 15% and 20% annualized seems modest over 5 years (2.01x vs 2.49x) but becomes enormous over 20 years (16.4x vs 38.3x). This is why protecting the compounding rate matters more than maximizing any single year's return.
Permanent capital loss. A 50% loss requires a 100% gain to break even. A single catastrophic loss can destroy a decade of compounding. Avoiding permanent loss is more important than capturing maximum upside.
Interruption. Every time you sell a compounder and buy something else, you reset the compounding clock, incur transaction costs and taxes, and introduce reinvestment risk. The frictional cost of turnover is far higher than most investors realize.
Mediocre reinvestment. If you compound at 20% for 5 years, sell, then reinvest at 10% for the next 5 years, your total 10-year CAGR is roughly 15% — not 20%. Compounding only works at full power when you remain invested in high-quality assets continuously.
Li Jie uses sustained ROE as the primary filter for quality. His hierarchy:
| ROE Range | Classification | Action |
|---|---|---|
| > 20% sustained 5+ years | Exceptional (卓越) | Core holding candidate |
| 15-20% sustained 5+ years | Excellent (优秀) | Strong candidate |
| 12-15% sustained 5+ years | Good (良好) | Acceptable if other factors strong |
| < 12% sustained | Mediocre (平庸) | Avoid — cannot compound effectively |
Critical rule: ROE must be sustained, not cyclical. A company that earned 25% ROE in a boom year and 5% in a downturn has an average ROE of 15% but is NOT a quality compounder. True compounders maintain ROE above 15% through full economic cycles.
Not all ROE is created equal. Li Jie ranks the sources of ROE by sustainability:
High net margin (best). Indicates pricing power, brand strength, or unique IP. Examples: Moutai (贵州茅台), leading pharma companies. High-margin ROE is the most durable because it does not depend on leverage or extreme efficiency.
High asset turnover (good). Indicates operational excellence and scale advantages. Examples: leading retailers, consumer staples distributors. Turnover- driven ROE is stable but requires continuous operational discipline.
High financial leverage (worst). Indicates borrowed returns. Leverage-driven ROE is fragile — it amplifies gains in good times and creates existential risk in bad times. Avoid companies whose ROE depends primarily on debt.
Implementation rule: Decompose ROE into margin, turnover, and leverage. Prefer companies where at least 60% of ROE comes from margin and turnover combined, with debt-to-equity below 1.0 for non-financial companies.
Li Jie adapts Buffett's moat framework with Chinese-market specifics:
| Moat Type | Description | Durability | Examples |
|---|---|---|---|
| Brand / pricing power | Consumer willing to pay premium; no close substitute | Very high | Moutai, Haitian Soy Sauce |
| Switching costs | Customer locked in by integration, data, or habit | High | Enterprise software, banking |
| Network effects | Value increases with each additional user | Very high (rare) | Tencent, Alibaba platforms |
| Cost advantage (scale) | Unit economics improve with volume; new entrant cannot match | High | Leading home appliance makers |
| Regulatory / license | Government approval creates barrier | Moderate (policy risk) | Banking licenses, pharma approvals |
| Intangible assets / IP | Patents, proprietary technology, unique know-how | Variable | Leading pharma R&D pipelines |
Minimum moat requirement: A quality company must have at least one clearly identifiable moat that has been tested in at least one economic downturn and survived intact.
| Factor | What to Look For | Red Flag |
|---|---|---|
| Capital allocation | High ROIC reinvestment, disciplined M&A, buybacks at low valuation | Empire-building acquisitions, vanity projects |
| Shareholder alignment | Significant insider ownership, consistent dividends | Excessive dilution, pledged shares |
| Track record | Promises met over 5+ year history | Frequent strategy pivots, missed guidance |
| Integrity | Transparent reporting, conservative accounting | Related-party transactions, aggressive revenue recognition |
| Industry vision | Understanding of secular trends, proactive positioning | Reactive, copying competitors |
Hard rule: If management has a history of shareholder-unfriendly capital allocation (excessive dilution, overpriced acquisitions, value-destroying diversification), disqualify the company regardless of other merits.
| Metric | Minimum Standard |
|---|---|
| ROE (5-year average) | >= 15% |
| Revenue growth (5-year CAGR) | >= 10% |
| Net margin stability | Standard deviation < 5 pct pts over 5 years |
| Free cash flow | Positive in at least 4 of last 5 years |
| FCF / Net income | >= 70% average over 5 years |
| Debt-to-equity (non-financial) | < 1.0 |
| Interest coverage | > 5x |
| Dividend payout | > 0% (some return to shareholders) |
| Goodwill / Total assets | < 20% |
Li Jie uses a simplified DCF anchored on owner earnings, not reported EPS:
Owner Earnings = Net Income + Depreciation/Amortization - Maintenance CapEx
≈ Free Cash Flow (in most cases)
Intrinsic Value = Owner Earnings × Justified P/E Multiple
Where Justified P/E = f(growth rate, ROE sustainability, moat durability)
| Growth + Quality Profile | Justified P/E Range |
|---|---|
| Exceptional moat + 20%+ growth | 25-35x |
| Strong moat + 15-20% growth | 20-28x |
| Good moat + 10-15% growth | 15-22x |
| Moderate moat + 5-10% growth | 12-17x |
| Weak/no moat + < 5% growth | 8-12x |
Adjustment factors:
Li Jie defines explicit margin-of-safety requirements based on conviction level:
| Conviction Level | Required Discount to Intrinsic Value |
|---|---|
| Very high (deep understanding, proven compounder) | >= 20% |
| High (strong analysis, some uncertainty) | >= 30% |
| Moderate (reasonable thesis, material unknowns) | >= 40% |
| Low (speculative, unproven) | Do not buy |
Operational rule: Never buy any stock trading above estimated intrinsic value, regardless of narrative, momentum, or fear of missing out. The margin of safety is non-negotiable.
No single valuation method is sufficient. Li Jie requires at least two confirming methods:
P/E relative to historical range. Where does the current P/E sit in the company's own 5-year and 10-year P/E range? Below median is preferred; below 25th percentile is ideal.
PEG ratio. P/E divided by expected earnings growth rate. PEG < 1.0 is attractive; PEG < 0.7 is compelling; PEG > 1.5 for a non-exceptional business signals overvaluation.
EV/EBIT. Enterprise value relative to operating earnings. Useful for comparing companies with different capital structures. Target EV/EBIT < 15 for most quality businesses.
Dividend yield floor. For mature compounders, a dividend yield above the historical average provides a valuation floor. When yield is in the top quartile of its historical range, the stock is likely undervalued.
FCF yield. Free cash flow / market cap. FCF yield > 5% for a quality business is attractive; > 7% is compelling.
Li Jie's central analytical framework evaluates every investment on three independent dimensions. All three must be favorable for a position to be initiated.
This answers: "Is this a business that can compound value over the long term?"
Checklist:
Scoring: Assign 0-10. Minimum threshold: 7/10.
This answers: "Am I paying less than the business is worth?"
Checklist:
Scoring: Assign 0-10. Minimum threshold: 6/10.
This answers: "Are conditions favorable for the compounding to begin working?"
Li Jie is explicit that timing does NOT mean technical market timing or chart patterns. It means evaluating the macro and business-cycle context:
Checklist:
Scoring: Assign 0-10. Minimum threshold: 5/10.
Composite Score = Business Score × 0.50 + Price Score × 0.35 + Timing Score × 0.15
Minimum for investment: Composite >= 7.0
All three individual dimensions must meet minimum thresholds.
Li Jie advocates concentration in high-conviction ideas. Diversification is a hedge against ignorance; the compounder seeks deep knowledge of fewer names.
| Portfolio Tier | Number of Holdings | Allocation per Position |
|---|---|---|
| Core holdings (highest conviction) | 3-5 | 10-20% each |
| Supporting holdings (strong conviction) | 3-5 | 5-10% each |
| Watch positions (building conviction) | 2-5 | 2-5% each |
| Total portfolio | 8-15 | 100% |
Li Jie recommends pyramiding into positions:
Phase 1 (Initial): Buy 30% of planned full position at first target price.
Phase 2 (Confirm): Buy 40% after first earnings report confirms thesis.
Phase 3 (Complete): Buy remaining 30% on any pullback or continued confirmation.
Timeline: 3-6 months from initial buy to full position.
If the stock rises 20%+ before the position is fully built, do NOT chase. Accept the smaller position and wait for a pullback or reallocate the capital elsewhere.
Li Jie's core behavioral requirement: once you own a quality compounder at a fair price, your default action is to hold. The burden of proof is on selling, not on holding.
Holding framework:
Li Jie provides explicit rules for drawdown situations:
| Drawdown | Business Intact? | Action |
|---|---|---|
| -10 to -20% | Yes | Hold. This is normal volatility. |
| -10 to -20% | Uncertain | Review thesis. If thesis intact, hold. |
| -20 to -30% | Yes | Consider adding to position if below intrinsic value. |
| -20 to -30% | No | Reduce position by 30-50%. |
| > -30% | Yes | Strong buy if conviction high and cash available. |
| > -30% | No | Exit immediately. |
The key distinction is always between price decline (temporary) and value decline (potentially permanent). The compounder adds to positions during price declines and exits during value declines.
Li Jie limits selling to three clearly defined scenarios:
Trigger 1: Business deterioration. The competitive advantage that justified the original investment has weakened materially. Signs include:
Action: Sell 100% within 1-2 weeks of reaching this conclusion. Do not average down on a deteriorating business.
Trigger 2: Extreme overvaluation. The stock price has risen far above any reasonable intrinsic value estimate. Li Jie defines "extreme" as:
Action: Trim 30-50% of the position. Retain the remainder in case the business grows into the valuation. Sell the full position only if valuation reaches 2.5x+ justified P/E.
Trigger 3: Clearly superior opportunity. You have identified a new investment that scores higher on all three dimensions (business quality, price, timing) and you have no available cash. This is the rarest sell trigger.
Action: Swap no more than 50% of the lower-conviction position to fund the new idea. Never sell 100% of a proven compounder to fund an unproven idea.
Li Jie categorizes risk by severity and controllability:
| Risk Level | Type | Mitigation |
|---|---|---|
| 1 (highest) | Permanent capital loss | Margin of safety, quality filter, position limits |
| 2 | Business model disruption | Continuous moat monitoring, sector diversification |
| 3 | Valuation compression | Buy below intrinsic value, patience |
| 4 | Liquidity risk | Avoid micro-caps, maintain cash buffer |
| 5 (lowest) | Short-term volatility | Ignore it — this is the price of compounding |
Before initiating any position, answer these questions:
| Rule | Threshold |
|---|---|
| Maximum single position (at cost) | 20% |
| Maximum single position (at market) | 30% (trigger trim) |
| Maximum single sector | 40% |
| Maximum correlation cluster | 50% (e.g., all consumer + all China GDP-sensitive) |
| Minimum number of holdings | 8 |
| Maximum leverage | 0% (never use margin) |
| Cash reserve floor | 5% |
Li Jie argues that a well-constructed compounding portfolio should benefit from volatility, not merely survive it. When the market panics:
The worst thing you can do during a crisis is become a forced seller yourself. This is why: no leverage, always maintain cash, and hold positions sized so that drawdowns are psychologically bearable.
| Rule # | Rule | Rationale |
|---|---|---|
| 1 | Never buy or sell based on a single day's price action | Compounding operates on business fundamentals, not daily noise |
| 2 | Never increase a position that is already at maximum size | Concentration kills compounding through catastrophic loss |
| 3 | Never skip the valuation step, no matter how good the business | Overpaying for quality still destroys returns |
| 4 | Write down the thesis before buying; revisit annually | Forces clarity, prevents narrative drift |
| 5 | When in doubt, do nothing | The compounding default is to hold |
| 6 | Never act on tips, rumors, or social media sentiment | These attract the worst behavioral impulses |
| 7 | Track business metrics, not stock price | Revenue, earnings, ROE, FCF — these are what matter |
| 8 | Keep an investment journal | Record decisions and reasoning for future review |
| 9 | Review mistakes annually | Post-mortems build pattern recognition |
| 10 | Measure performance over rolling 3-year periods minimum | Short-term measurement creates short-term behavior |
When you feel the urge to make a trade, Li Jie prescribes a 72-hour cooling period:
Exception: the only scenario exempt from the 72-hour rule is evidence of fraud or fundamental business failure. In those cases, sell immediately.
| Bias | How It Manifests | Defense |
|---|---|---|
| Anchoring | Fixating on purchase price or historical high | Value business on current fundamentals, not past prices |
| Confirmation bias | Seeking information that supports existing position | Actively seek disconfirming evidence; assign a "devil's advocate" review |
| Loss aversion | Holding losers too long, selling winners too early | Focus on intrinsic value change, not P&L |
| Recency bias | Overweighting recent events in forecasting | Use 5-10 year data windows, not 1-2 quarters |
| Herding | Following consensus into crowded trades | Maintain independent research process; be suspicious of consensus |
| Overconfidence | Oversizing positions, underestimating risk | Mandate margin of safety; hard position limits |
Selling winners to buy losers. The instinct to "rebalance" by selling your best performer and adding to your worst is backwards. Winners are winning because the business is compounding. Losers may be losing because the business is deteriorating. Always evaluate on business merit, not on P&L.
Confusing cyclical recovery with secular growth. A company whose earnings double off a cyclical trough is not the same as a company growing earnings 15% per year sustainably. Buying cyclicals at peak earnings (which look like low P/E) is a classic value trap.
Diversifying into mediocrity. Adding a 15th, 20th, or 30th position because it "looks interesting" dilutes the portfolio's quality. Every new position must clear the same quality bar as existing holdings.
Ignoring the balance sheet. A company with 25% ROE and 3x leverage is not the same as one with 25% ROE and no debt. Leverage-driven ROE is fragile and can collapse catastrophically.
Chasing past performance. Buying a stock because it went up 300% last year. The compounding happened for previous shareholders. What matters is the forward return from today's price.
Impatience with the process. Compounding at 20% per year means your money roughly doubles every 3.6 years. In year one, the absolute gains feel small. Many investors abandon the strategy before it has time to work.
Treating stock investing as entertainment. Trading for the thrill of it, checking prices constantly, celebrating daily gains and mourning daily losses. This behavior is incompatible with compounding.
Buying cheap rather than buying quality. A stock trading at 8x earnings may be cheap for good reason — the business is declining. A stock at 25x earnings may be the better value if the business will compound at 20% for a decade.
Ignoring opportunity cost. Holding cash for "safety" when quality businesses are available at fair value. Cash earns 0-3% and is a guaranteed compounding underperformer over long horizons.
Failing to distinguish volatility from risk. A 30% drawdown in a quality business is volatility (temporary). A 30% decline due to competitive displacement is risk (permanent). The correct response to each is opposite.
Phase 1: Screening (Week 1)
The investor screens for companies with:
Company X, a leading soy sauce manufacturer, passes all screens:
Phase 2: Deep Analysis (Weeks 2-4)
Business quality (Dimension 1 - Good Business):
Valuation (Dimension 2 - Good Price):
Phase 3: Watchlist and Patience (Months 1-8)
The investor monitors quarterly earnings and waits for a better price. Eight months later, a broad market selloff (unrelated to the company) pushes the stock down 25%.
Updated valuation:
Timing (Dimension 3 - Good Timing):
Composite score: 9 × 0.50 + 8 × 0.35 + 7 × 0.15 = 4.50 + 2.80 + 1.05 = 8.35 Well above the 7.0 minimum. Proceed.
Phase 4: Position Building (Months 8-12)
Full position: 10% of portfolio. Classification: Supporting holding.
Phase 5: Holding and Monitoring (Years 1-5)
Position is now worth 2.1x initial investment (including dividends reinvested). CAGR: approximately 16%. Continue holding.
Phase 6: Eventual Exit (Year 7)
In year 7, a new regulatory framework significantly increases production compliance costs for the entire industry. Company X can absorb the costs due to scale, but net margin drops from 20% to 15%. ROE falls to 17%. At the same time, a technology-forward competitor is gaining share rapidly with a direct-to-consumer model.
Assessment: Moat is weakening, though not destroyed. ROE still above 15% but trajectory is negative. Competitive landscape shifting.
Decision: Reduce position from 15% to 7%. Redeploy capital to a higher-conviction holding. Continue monitoring the reduced position.
In year 8, margins stabilize at 15% but market share loss accelerates. ROE drops to 14% — below the 15% minimum threshold. Sell trigger 1 (business deterioration) activated.
Decision: Exit remaining position. Total holding period: 8 years. Total return: approximately 3.5x (including dividends). CAGR: approximately 17%.
"复利的第一条铁律是：永远不要亏损。第二条铁律是：永远不要忘记第一条。" "The first iron law of compounding: never lose money. The second iron law: never forget the first."
"时间是优秀企业的朋友，是平庸企业的敌人。" "Time is the friend of a wonderful business and the enemy of a mediocre one."
"投资中最难的不是找到好公司，而是在找到好公司后什么都不做。" "The hardest part of investing is not finding good companies — it is doing nothing after you have found them."
"真正的复利信徒不关注一年赚了多少，只关注十年后能赚多少。" "A true compound interest believer does not care how much he earns in a year; he only cares about how much he will earn in a decade."
"好公司不等于好投资。好公司加好价格才等于好投资。" "A good company does not equal a good investment. A good company at a good price equals a good investment."
"大多数投资者不是死于熊市的恐惧，而是死于牛市的贪婪。" "Most investors do not die from bear market fear — they die from bull market greed."
"持有优秀公司的最大成本不是资金，而是耐心。" "The greatest cost of holding an excellent company is not capital — it is patience."
"当你的股票下跌30%而你想卖出时，问自己：如果我没有持有这只股票，我会在这个价格买入吗？如果答案是肯定的，那就继续持有。" "When your stock drops 30% and you want to sell, ask yourself: if I did not already own it, would I buy it at this price? If the answer is yes, keep holding."
"投资组合应该像一个球队，每个成员都必须是精英，而不是像一个村庄，什么人都有。" "A portfolio should be like a championship team where every member is elite, not like a village where anyone is welcome."
"频繁交易是复利的天敌。每一次买卖都是对复利链条的一次打断。" "Frequent trading is the mortal enemy of compounding. Every buy and sell interrupts the compounding chain."
End of implementation specification.